🦊/Companies

Biomarx

4 known investors

Find your way into Biomarx

Biomarx develops automated liquid biopsy diagnostics using biosensing technologies for early cancer and disease detection, delivering test results in under two hours at low cost. Its products target clinicians and healthcare providers seeking rapid, affordable precision diagnostics for personalised medicine.

Founders & leadership

SMSean Macfarlane
Sean MacfarlaneinFounder

Investors · 4

Also in the syndicate · 1

University of Strathclyde

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Companies House · registry record

View on Companies House ↗
Registered name
BIOMARX LTD
Company number
NI726102
Status
Active
Company type
Private limited company
Incorporated
6 Feb 2025
Registered office
26 Ravenhill Park, Belfast, BT6 0DE
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts
last made up to 30 Nov 2025 · next due 31 Aug 2027
Confirmation statement
last made up to 5 Feb 2026 · next due 19 Feb 2027

Current officers · 2

  • Alex Catherine Harkin director, appointed 1 Jan 2026
  • Sean Macfarlane director, appointed 6 Feb 2025

Source: Companies House public register · retrieved 9 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Frequently asked questions

What does Biomarx do?
Biomarx develops automated liquid biopsy diagnostics using biosensing technologies for early cancer and disease detection, delivering test results in under two hours at low cost. Its products target clinicians and healthcare providers seeking rapid, affordable precision diagnostics for personalised medicine.
Who founded Biomarx?
Biomarx was founded by Sean Macfarlane.
Who are Biomarx's investors?
Biomarx's investors include Clarendon Fund Managers Ltd., SFC Capital, Techstart Ventures.